PL125030B1 - Method of manufacture of novel derivatives of 4-aminoquinoline-3-carboxylic acid - Google Patents

Method of manufacture of novel derivatives of 4-aminoquinoline-3-carboxylic acid Download PDF

Info

Publication number
PL125030B1
PL125030B1 PL1980222993A PL22299380A PL125030B1 PL 125030 B1 PL125030 B1 PL 125030B1 PL 1980222993 A PL1980222993 A PL 1980222993A PL 22299380 A PL22299380 A PL 22299380A PL 125030 B1 PL125030 B1 PL 125030B1
Authority
PL
Poland
Prior art keywords
preparation
carboxylic acid
ethyl ester
lower alkyl
acid ethyl
Prior art date
Application number
PL1980222993A
Other languages
English (en)
Polish (pl)
Other versions
PL222993A1 (OSRAM
Inventor
Harry R Munson
Reevis S Alphin
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of PL222993A1 publication Critical patent/PL222993A1/xx
Publication of PL125030B1 publication Critical patent/PL125030B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL1980222993A 1979-03-26 1980-03-25 Method of manufacture of novel derivatives of 4-aminoquinoline-3-carboxylic acid PL125030B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (2)

Publication Number Publication Date
PL222993A1 PL222993A1 (OSRAM) 1981-01-30
PL125030B1 true PL125030B1 (en) 1983-03-31

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1980222993A PL125030B1 (en) 1979-03-26 1980-03-25 Method of manufacture of novel derivatives of 4-aminoquinoline-3-carboxylic acid

Country Status (31)

Country Link
US (1) US4343804A (OSRAM)
JP (1) JPH02117663A (OSRAM)
AR (1) AR230268A1 (OSRAM)
AT (1) AT372373B (OSRAM)
AU (1) AU528388B2 (OSRAM)
BR (1) BR8001779A (OSRAM)
CA (1) CA1147338A (OSRAM)
CH (1) CH644105A5 (OSRAM)
DE (1) DE3011490A1 (OSRAM)
DK (1) DK156056C (OSRAM)
EG (1) EG15009A (OSRAM)
ES (1) ES8103048A1 (OSRAM)
FI (1) FI77452C (OSRAM)
FR (1) FR2452485B1 (OSRAM)
GB (1) GB2047244B (OSRAM)
GR (1) GR68006B (OSRAM)
HK (1) HK67983A (OSRAM)
IE (1) IE49577B1 (OSRAM)
IL (1) IL59628A (OSRAM)
IN (1) IN151446B (OSRAM)
IT (1) IT1133079B (OSRAM)
MX (1) MX6264E (OSRAM)
NL (1) NL8001752A (OSRAM)
NO (1) NO153927C (OSRAM)
NZ (1) NZ193252A (OSRAM)
PH (1) PH16416A (OSRAM)
PL (1) PL125030B1 (OSRAM)
PT (1) PT71008B (OSRAM)
SE (1) SE435837B (OSRAM)
SG (1) SG33683G (OSRAM)
YU (1) YU41702B (OSRAM)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
EP0720601B1 (en) * 1993-08-10 2000-10-25 James Black Foundation Limited Gastrin and cck receptor ligands
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
HU230728B1 (hu) 1998-09-29 2017-12-28 Wyeth Holdings Llc Szubsztituált 3-cianokinolinok mint protein tirozin kinázok inhibitorai
WO2001047891A1 (en) * 1999-12-28 2001-07-05 Eisai Co., Ltd. Heterocyclic compounds having sulfonamide groups
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ES2295816T3 (es) 2003-01-14 2008-04-16 Arena Pharmaceuticals, Inc. Derivados arilo y heteroarilo 1,2,3-trisustituidos como moduladores del metabolismo, y profilaxis y tratamiento de transtornos relacionados con los mismos, tales como la diabetes y la hiperglucemia.
HRP20050399B1 (hr) 2003-03-10 2013-09-30 Takeda Gmbh Novi postupci za dobivanje roflumilasta
US7132426B2 (en) * 2003-07-14 2006-11-07 Arena Pharmaceuticals, Inc. Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
WO2011022216A1 (en) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
SG10201500639TA (en) 2010-01-27 2015-03-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
EP2619198A1 (en) 2010-09-22 2013-07-31 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
PL3242666T3 (pl) 2015-01-06 2025-02-17 Arena Pharmaceuticals, Inc. Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
JP6838744B2 (ja) 2015-06-22 2021-03-03 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩
ES2884073T3 (es) * 2016-11-11 2021-12-10 Bayer Animal Health Gmbh Nuevos derivados antihelmínticos de quinolina-3-carboxamida
AU2018220521A1 (en) 2017-02-16 2019-09-05 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
EP3700527A4 (en) * 2017-10-25 2021-03-10 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHOD OF USING THEM
EP3790874B1 (en) 2018-05-09 2023-03-15 Bayer Animal Health GmbH Anthelmintic quinoline derivatives
KR102859841B1 (ko) 2018-06-06 2025-09-12 아레나 파마슈티칼스, 인크. S1p1 수용체와 관련된 병태의 치료 방법
CN119798159A (zh) 2019-04-24 2025-04-11 儿童医学中心公司 Papd5抑制剂及其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
JPS4838712A (OSRAM) * 1971-09-18 1973-06-07

Also Published As

Publication number Publication date
DK128380A (da) 1980-09-27
DK156056C (da) 1989-11-06
FI800910A7 (fi) 1980-09-27
ES489887A0 (es) 1981-02-16
IT8067465A0 (it) 1980-03-26
CA1147338A (en) 1983-05-31
BR8001779A (pt) 1980-11-18
FR2452485B1 (fr) 1986-09-12
IN151446B (OSRAM) 1983-04-23
AT372373B (de) 1983-09-26
NO800858L (no) 1980-09-29
IE800605L (en) 1980-09-26
SG33683G (en) 1985-03-29
PL222993A1 (OSRAM) 1981-01-30
FI77452B (fi) 1988-11-30
DE3011490A1 (de) 1981-03-12
ES8103048A1 (es) 1981-02-16
DK156056B (da) 1989-06-19
SE435837B (sv) 1984-10-22
YU84480A (en) 1983-10-31
IL59628A0 (en) 1980-06-30
AU528388B2 (en) 1983-04-28
FR2452485A1 (fr) 1980-10-24
NZ193252A (en) 1984-04-27
HK67983A (en) 1983-12-23
IL59628A (en) 1983-06-15
PH16416A (en) 1983-09-29
GR68006B (OSRAM) 1981-10-26
MX6264E (es) 1985-02-19
PT71008A (en) 1980-04-01
SE8002292L (sv) 1980-09-27
FI77452C (fi) 1989-03-10
IT1133079B (it) 1986-07-09
IE49577B1 (en) 1985-10-30
DE3011490C2 (OSRAM) 1988-12-22
PT71008B (en) 1981-06-25
GB2047244B (en) 1983-02-23
NL8001752A (nl) 1980-09-30
AR230268A1 (es) 1984-03-01
US4343804A (en) 1982-08-10
YU41702B (en) 1987-12-31
NO153927B (no) 1986-03-10
AU5684880A (en) 1980-10-02
NO153927C (no) 1986-06-18
EG15009A (en) 1985-03-31
CH644105A5 (fr) 1984-07-13
JPH02117663A (ja) 1990-05-02
ATA156480A (de) 1983-02-15
GB2047244A (en) 1980-11-26

Similar Documents

Publication Publication Date Title
PL125030B1 (en) Method of manufacture of novel derivatives of 4-aminoquinoline-3-carboxylic acid
DE3486043T2 (de) Chinolinzwischenprodukte fuer die synthese von 1h-imidazo(4,5-c)chinolinen und 1h-imidazo(4,5-c)chinolin-4-aminen.
US4738971A (en) N-aryl-1,2-dihydro-4-substituted-1-alkyl-2-oxo-quinoline-3-carboxamides
US4902693A (en) Anti-allergic esters, acetal ethers, thioethers and nitrogen substituted derivatives of bicyclic compounds
NZ227125A (en) Quinazoline derivatives and pharmaceutical compositions
DE2740588A1 (de) Imidazo- eckige klammer auf 1,2-a eckige klammer zu -chinolin-2-carbon- saeuren und deren derivate sowie pharmazeutische zubereitungen, die diese verbindungen enthalten
EP0151962A2 (en) Pyrazolopyridine derivatives
NZ211166A (en) Pyrazolopyridines and pharmaceutical compositions
PL176424B1 (pl) Alkoksyalkilokarbaminiany imidazo [1,2-a] pirydyn, sposób ich wytwarzania i zawierający je środek leczniczy
US4284768A (en) 1,2-Dihydro-4-amino-2-oxo-3-quinoline-carboxylic acid derivatives
PL96888B1 (pl) Sposob wytwarzania nowych benzyloamin
US5137890A (en) 4-phenyl tetrahydropyrido(4,3-d)pyrimidines
US4578465A (en) Phenyliperazine derivatives
US4187306A (en) Benzodiazepine-diones, a process for their production and their use as medicaments
PL139428B1 (en) Method of obtaining substituted thienobenzodiazepinones
IE47249B1 (en) 4-aminoquinoline derivatives
PL116688B1 (en) Process for the preparation of trinuclear compounds with nitrogen atom in nodal position
PL80193B1 (OSRAM)
KR840000768B1 (ko) 4-아미노-3-퀴놀린카복실산 및 에스테르의 제조방법
JPS62169783A (ja) イミダゾ〔１，２−ａ〕キノリン誘導体、その製造法およびその医薬への応用
FI96417C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi
CA1161757A (en) 4-amino-3-quinolinecarboxylic acids and esters- antisecretory, anti-ulcer compounds
CS216527B2 (cs) Způsob výroby 4-amino-3-chinolinkarboxylových kyselin a jejich esterů
US4818754A (en) Certain anti-inflammatory pyrazolo [4,3-b] pyridine 7-amines
EP0107165A1 (en) Substituted 9H-8-oxo-pyrimido(2,1-f)purine-2,4-diones, process for their production and pharmaceutical compositions containing them